Prevalence of Demodex Blepharitis in Japan and Europe
An expert discusses the prevalence and clinical impact of Demodex blepharitis across Japan and Europe, highlighting regional differences in diagnosis and awareness.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
